TransEnterix, Inc. TRXC, +4.13% a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that it has received Japanese regulatory approval for the Senhance™ Surgical System. “Regulatory approval in Japan is a pivotal milestone for our company, as Japan is second only to the U.S....
*****************armata-pharmaceuticals-announces-publication-of-successful-adjunctive-phage-treatment-in-cystic-fibrosis-patient************** Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based...
***** On the watch-list for possible breakout today after unusual volume at the end of last week for no apparent reason. Possibly some sort of announcement is on the schedule for this week, it has caught the attention of many speculators on social media and forums etc, so any move will be frantic. COMPANY PROFILE Nobilis Health Corp. engages in the operation...
It is so appealing to go for a long entry in OTC:CWBHF pre earnings, because it has been beaten down quite badly, but there may be just more downside and a better entry point. The technical indicators are all heading south and sell side volume continues to be high. If it were to drop out of the golden pocket below $14 it is a short to $8. AVERAGE ANALYSTS PRICE...
Upgrades galore for NASDAQ:PIRS lately as analysts see great upside potential for the company. Most recently PIRS presented data from a phase 1 study on its new technology ANTICALIN which it is developing in collaboration with NYSE:AZN was released and commented on by the Chief development officer. "We are encouraged by the safety and tolerability of...
IT HAS ALREADY BEEN A EVENTFUL WEEK FOR NASDAQ:TNXP WITH CAPITAL RAISE ISSUES AND A NEW PIPELINE DRUG CANDIDATE UPDATE. NEST WEEK COULD BE EQUALLY IMPORTANT AS ON TUESDAY THE COMPANY RELEASES DATA ON TNX-102 PHARMACOKINTEC . THE STOCK IS SETTING UP NICELY FOR THE WEEK TO COME. COMPANY PROFILE Tonix Pharmaceuticals Holding Corp. is a clinical-stage...
In recent analysis by J Mintzmer he makes come very positive points regarding NYSE:STNG he wrote "Scorpio Tankers (STNG) has the world's largest fleet of modern product tankers. With major fuel regulations pending in 2020, product markets are poised to surge.Scorpio Tankers (NYSE:STNG) is a product tanker pure-play with the world's largest publicly-traded fleet...
United Continental Airlines yesterday was the Knight in shinning Armour for investors in NYSE:AVH as the battle commences to keep their planes in the air. They company is crippled with debt has a very limited fleet of old planes after leasing companies took repossession after repayments were defaulted upon. UCA will now loan the company money and build its own...
Revolution Lighting Technologies stated Friday that on May 22, 2019, the Company received a letter from the Nasdaq Hearings Panel of The Nasdaq Stock Market informing the Company that the Panel has granted the Company’s request to stay the suspension of the Company’s securities from Nasdaq pending a final determination from the Panel regarding the Company’s...
Heightened tension between China and the USA have had a massive impact on the stock of NYSE:NIO but that is not the only reason. The stock finds itself at a all time low after producing very poor earnings in the previous quarter and that is unlikely to change. Competition within the sector is also mounting as the displacement away from gas intensifies, which...
Difficult to build a case for this as it is purely speculation and rumor that has highlighted the stock of NASDAQ:CLVS . There has been some option activity which is encouraging and positive trial data which failed to rally the stock. The contrarian long option is going against strong negatives such as, high debt, decreasing pricing power, insider selling and...
It has become a real "I'm the biggest Bear" among the Analysts community to get a ridiculously low downgrade onto the CNBC Merry go round. Today may be the final day for the Bears to party, Gene Munster today was less than complementary regarding TSLA's future under Musk, he is a highly regarded analyst and his opinion counts. The fact he did not make a silly...
*********alert ******* NASDAQ:SANW STOCK HAS BEEN Halted this morning on unusual volume and news pending within conference call at 11.00 ET . Stock had gaped up 24% before been halted, strong watch for today ANALYSTS PRICE TARGET $4.83 ANALYSTS RECOMMENDATION BUY COMPANY PROFILE S&W Seed Co. is an agricultural company, which engages in the production and...
Shares of LB have rallied on Thursday morning as a result of the company announcing a surprise profit in the quarter and also raising guidance for the year to come. This could result in a massive rally in the days to come as the stock has lost 40% of value in 6 months and was actually down 5% yesterday prior to the earnings report. COMPANY PROFILE L Brands, Inc....
*****CONTINUATION LOOKS ON THE CARDS TODAY, STRONG GAINS THE AFTER HOURS ONCE AGAIN ON GOOD VOLUME . CURRENTLY ON RESISTANCE AT $18 A BREAK COULD BE VERY REWARDING. ***********NEWS FLOW********* The FDA designates Iovance Biotherapeutics' (NASDAQ:IOVA) LN-145 a Breakthrough Therapy for the treatment of recurrent, metastatic, or persistent cervical cancer that...
************************A CAVALCADE OF GOOD NEWS LATELY IN NASDAQ:NOVN HAS SPURNED A EPIC RALLY FROM LATE APRIL. NOT TO WORRY IF YOU HAVE NOT BEEN INVOLVED THERE IS PLENTY OF ACTION LEFT IN THIS NAME AS INSIDERS HAVE BEEN BUYING UP SHARES. A BREAK ABOVE $2.45 IS A GOOD BUY SIGNAL ON GOOD VOLUME ********************* On May 6, it announced that it sold the...
****** HUGE MOVE ON THE WAY TODAY, THIS COULD REALLY ROCKET HIGHER****************** Thinly traded micro cap Valeritas Holdings (NASDAQ:VLRX) is up 38% premarket on increased volume in reaction to new data from the VERDICT study, a real-world retrospective analysis of electronic medical records from a large diabetes center. Patients with HbA1c levels greater...
*****SPECULATION IS WE COULD GET A SIZEABLE MOVE IN THE STOCK TODAY WITH W EASY 30% GAIN********************* SET ALERTS FOR A POSSIBLE MOVE TO ABOVE $2 AVERAGE PRICE TARGET $9 AVERAGE RECOMMENDATION buy LEAP THERAPEUTICS INC. Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat...